Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial

2021446 citationsJournal Articlehybrid Open Access

Authors

Mehreen S. Datoo · Jenner Institute

Hamtandi Magloire Natama · Institut de Recherche en Sciences de la Santé

Anyirékun Fabrice Somé · Institut de Recherche en Sciences de la Santé

Ousmane Traoré · Institut de Recherche en Sciences de la Santé

Toussaint Rouamba · Institut de Recherche en Sciences de la Santé

Duncan Bellamy · Jenner Institute

Prisca Yameogo

Abstract

The European & Developing Countries Clinical Trials Partnership, Wellcome Trust, and National Institute for Health Research Oxford Biomedical Research Centre.

Topics & Keywords

Malaria Research and Control Mosquito-borne diseases and control Global Maternal and Child Health

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: The Lancet

Volume 397, Issue 10287, pp. 1809-1818

DOI: 10.1016/s0140-6736(21)00943-0

Field-Weighted Citation Impact: 69.74